Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
YM155
Description:
YM155 is an experimental small-molecule anticancer drug investigated for suppressing survivin and promoting tumor-cell death.
Related topic:
Cell death mechanisms and regulation (17%)
OpenAlex ID:
keywords/ym155
YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts
2007
·
Takahito Nakahara
, Masahiro Takeuchi
, et al.
·
Cancer Research
·
554
Survivin: A new target for anti-cancer therapy
2009
·
Bríd M. Ryan
, Norma O’Donovan
, et al.
·
Cancer Treatment Reviews
·
406
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
2008
·
Anthony W. Tolcher
, Alain Mita
, et al.
·
Journal of Clinical Oncology
·
263
PDF
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
2009
·
Giuseppe Giaccone
, Petr Zatloukal
, et al.
·
Journal of Clinical Oncology
·
262
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules
2013
·
Mi-Ok Lee
, Sung Hwan Moon
, et al.
·
Proceedings of the National Academy of Sciences
·
257
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
2009
·
Taroh Satoh
, Isamu Okamoto
, et al.
·
Clinical Cancer Research
·
187
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
2014
·
Georg E Winter
, Branka Radic
, et al.
·
Nature Chemical Biology
·
184
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
2013
·
R.J. Kelly
, A. Thomas
, et al.
·
Annals of Oncology
·
182
PDF
Broad spectrum and potent antitumor activities of YM155, a novel small‐molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
2010
·
Takahito Nakahara
, Aya Kita
, et al.
·
Cancer Science
·
174
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
2011
·
A.W. Tolcher
, D.I. Quinn
, et al.
·
Annals of Oncology
·
173
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
2021
·
Yao Zhao
, Xiaoyu Du
, et al.
·
Protein & Cell
·
160
PDF
Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines
2008
·
Tsutomu Iwasa
, Isamu Okamoto
, et al.
·
Clinical Cancer Research
·
159
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
2009
·
Karl D. Lewis
, Wolfram Samlowski
, et al.
·
Investigational New Drugs
·
152
Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
2012
·
Reety Arora
, Masahiro Shuda
, et al.
·
Science Translational Medicine
·
148
Survivin and YM155: How faithful is the liaison?
2014
·
Anke Rauch
, Dorle Hennig
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
145
d-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells
2014
·
Christiana M. Neophytou
, Constantina Constantinou
, et al.
·
Biochemical Pharmacology
·
132
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B‐cell lymphoma
2011
·
Bruce D. Cheson
, Nancy L. Bartlett
, et al.
·
Cancer
·
132
PDF
DrugTargetSeqR: a genomics- and CRISPR-Cas9–based method to analyze drug targets
2014
·
Corynn Kasap
, Olivier Elemento
, et al.
·
Nature Chemical Biology
·
129
Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
2011
·
Kentaro Yamanaka
, Takahito Nakahara
, et al.
·
Clinical Cancer Research
·
115
Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.
2012
·
Qiuying Cheng
, Xiang Ling
, et al.
·
Europe PMC (PubMed Central)
·
114
An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro
2011
·
Wei Li
, Hang Wang
, et al.
·
Molecular and Cellular Biochemistry
·
113
PDF
Survivin in Solid Tumors: Rationale for Development of Inhibitors
2012
·
David N. Church
, Denis C. Talbot
·
Current Oncology Reports
·
111
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer
2014
·
Ryunosuke Kogo
, Christine How
, et al.
·
Oncotarget
·
109
PDF
HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival
2015
·
Yuichi Mitobe
, Jun-ichirou Yasunaga
, et al.
·
Cancer Research
·
104
Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer
2013
·
Xue‐Pu Sun
, Xuesong Dong
, et al.
·
FEBS Journal
·
101
Show more works
View as search
Works count:
637
Citation count:
11,640
Year
Topic
Type